We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Normal Cells and Cancer Cells Differentiated by Degree of Protein Phosphorylation

By LabMedica International staff writers
Posted on 09 Dec 2009
Print article
Cancer researchers have developed a method to differentiate cancer and normal cells at the molecular level based on different degrees of protein phosphorylation.

At the molecular level, cancers are heterogeneous diseases, arising from genetic factors, environmental carcinogens, and random, somatic mutation. Phosphorylation of proteins is a key regulator of protein activity, and in particular, modification of tyrosine residues modulates critical signaling and control processes. In cancers, aberrant phosphorylation status of key residues (its presence or absence) has been observed and documented in many studies.

Investigators at Boston University (MA, USA) collaborated with specialists at Cell Signaling Technology (Danvers, MA, USA) in order to apply the "Phosphoscan" methodology to establish a comparative profile of the phosphorylation properties of proteins in normal and cancer cells.

They reported in the November 25, 2009, issue of the journal PLoS ONE that a large set of sites were differentially phosphorylated in tumors, many of which can be used as direct targets for new drugs. Furthermore they employed a novel computational approach to perform a protein variant of gene set enrichment analysis that showed that certain pathways were differentially activated, based on their global phosphorylation status. A relatively small number of phosphorylated peptides observed in that data could discriminate between normal tissue and tumors with a high degree of sensitivity and specificity.

"Identifying the phosphorylation status of proteins in cancer cells versus normal cells provides us with a unique ability to understand and perhaps intervene with the command and control center of cancer cells," said contributing author Dr. Simon Kasif, professor of biomedical engineering at Boston University. "Drugs are most effective on cancers when they attack the proteins that are activated."

Related Links:
Boston University
Cell Signaling Technology


Gold Member
Blood Gas Analyzer
GEM Premier 7000 with iQM3
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Silver Member
Rubella Infection ELISA
ReQuest RUBELLA IgM ELISA Kit
New
Food Allergens Assay Kit
Allerquant 14G A

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: The AI program analyzes a microscopy image from a tumor biopsy and determines what genes are likely turned on and off in the cells it contains (Photo courtesy of Olivier Gevaert/Stanford Medicine)

AI Tool ‘Sees’ Cancer Gene Signatures in Biopsy Images

To assess the type and severity of cancer, pathologists typically examine thin slices of a tumor biopsy under a microscope. However, to understand the genomic alterations driving the tumor's growth, scientists... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.